Findings from the COV-HI study, built in REDCap with support from the NJRO, have been published in The Lancet Rheumatology.

The study explored a specific phenotype of COVID-19-associated hyperinflammation (COV-HI), and its associations with escalation of respiratory support and survival. You can read the full journal entry here:

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30275-7/fulltext